H3K27M mutation in diffuse midline glioma is an independent predictor of overall survival however has a very poor prognosis. Identification of the mutation using conventional radiological analysis is complicated while the deep location of the tumors in the brain makes biopsy challenging with substantial risk of morbidity. To alleviate these issues, our work employs radiomics based machine learning framework to predict the H3K27M mutation from multi-modal MRI on 46 subjects. Results revealed 91% cross validation accuracy illustrating its future potential in clinical use.
This abstract and the presentation materials are available to members only; a login is required.